{"schema_version":"1","generated_at":"2026-11-04T09:28:43.601Z","data_as_of":null,"url":"https://www.findmykol.com/kol/willis-navarro","json_url":"https://www.findmykol.com/kol/willis-navarro/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"willis-navarro","name":"Willis Navarro","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Tucson","state":"AZ","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1871538421","orcid":"0000-0002-5033-3546","openalex":"A5007298083"},"summary":"Willis Navarro is an Oncology physician. OpenAlex indexes 109 publications with 1,673 citations (h-index 22); ClinicalTrials.gov lists 5 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":109,"cited_by_count":1673,"h_index":22,"latest_activity_year":2025,"source":"works"},"trials":{"count":5,"shown":3,"withheld":3,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT05997056","title":"Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors","phase":"PHASE2","status":"RECRUITING","role":"Overall official","sponsor":"Aadi Bioscience, Inc.","source_url":"https://clinicaltrials.gov/study/NCT05997056","trial_url":"https://www.findmykol.com/trial/NCT05997056"},{"nct":"NCT05997017","title":"Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer","phase":"PHASE2","status":"RECRUITING","role":"Overall official","sponsor":"Aadi Bioscience, Inc.","source_url":"https://clinicaltrials.gov/study/NCT05997017","trial_url":"https://www.findmykol.com/trial/NCT05997017"},{"nct":"NCT03010332","title":"Expanded Access Protocol of ATA230 (Third-Party Donor-Derived CMV-CTLs) for the Treatment of CMV Viremia or Disease","status":"NO_LONGER_AVAILABLE","role":"Overall official","sponsor":"Atara Biotherapeutics","source_url":"https://clinicaltrials.gov/study/NCT03010332","trial_url":"https://www.findmykol.com/trial/NCT03010332"}],"source":"trials"},"payments":{"company_count":3,"program_years":{"first":2021,"last":null},"rows_total":3,"shown":3,"withheld":0,"rows":[{"payer":"Incyte Corporation","program_year":2025,"amount_usd":202.7,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1871538421"},{"payer":"Amgen Inc.","program_year":2025,"amount_usd":143.16,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1871538421"},{"payer":"ABBVIE INC.","program_year":2025,"amount_usd":27.39,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1871538421"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1871538421","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein–Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial","year":2024,"journal":"The Lancet Oncology","source_url":"https://doi.org/10.1016/s1470-2045(23)00649-6","status":"verified"},{"title":"Phase II Trial of nab- Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update","year":2024,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.23.02266","status":"verified"},{"title":"UPLIFT (ENGOT-ov67/GOG-3048): Results from the phase II trial of upifitamab rilsodotin, a NaPi2b-directed dolaflexin antibody-drug conjugate, in platinum-resistant ovarian cancer","year":2024,"journal":"Gynecologic Oncology","source_url":"https://doi.org/10.1016/j.ygyno.2024.07.424","status":"verified"},{"title":"nab-Sirolimus plus letrozole in advanced or recurrent endometrioid endometrial cancer: A phase II, open-label, single-arm, prospective, multicenter study","year":2024,"journal":"Gynecologic Oncology","source_url":"https://doi.org/10.1016/j.ygyno.2024.07.425","status":"verified"},{"title":"A Phase 2 Study of the LSD1 Inhibitor Img-7289 (bomedemstat) for the Treatment of Essential Thrombocythemia (ET)","year":2021,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2021-148210","status":"verified"}],"source":"works"},"contact":{"address_1":"3838 N CAMPBELL AVE BLDG 1","city":"Tucson","state":"AZ","zip":"857191454","phone":"520-694-2873","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1871538421","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":3,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2024-11-07","provider_certified":"2024-11-07","collected_at":"2026-11-03T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}